PUBLIC submissions are now
being sought on medicines used
in the management of type 2
diabetes, with the move being
the next stage of the Post-Market
Review of the condition.
A six-week consultation period
will conclude on 02 Jul, with info
sought relating to the “utilisation
and patterns of treatment of PBS
listed T2DM medicines in current
clinical practice”.
The Dept of Health wants details
of any information, research and/
or experiences on the efficacy
and safety of current treatments
in contrast to alternative options,
and “whether prescribers and
consumers consider these
medicines are used effectively”.
Any information about preferred
medicines for specific subpopulations
of patients with type 2
diabetes is also being sought.
The overall review aims to
systematically evaluate clinical
evidence on diabetes to ensure the
most appropriate management of
the condition in clinical practice.
More info at www.pbs.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 23 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 May 13
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.